Viemed Healthcare, Inc. (VMD) stock
VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3016% below fair value
$9.07−0.08 (-0.87%)
Close on Nov 17, 2026Market cap $345.46MP/E 25.2Yield –
Viemed Healthcare operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Viemed Healthcare's operating income for the twelve months ending Jun 30, 2026 was $22.77M, up 8.3% year over year. For fiscal 2025 it was $22.95M, up 28.2% from the year before. The highest annual figure on record is $26.78M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.95M | +28.2% |
| FY2024 | Dec 31, 2024 | $17.90M | +24.9% |
| FY2023 | Dec 31, 2023 | $14.33M | +73.7% |
| FY2022 | Dec 31, 2022 | $8.25M | -28.7% |
| FY2021 | Dec 31, 2021 | $11.58M | -56.8% |
| FY2020 | Dec 31, 2020 | $26.78M | +202.4% |
| FY2019 | Dec 31, 2019 | $8.86M | -11.9% |
| FY2018 | Dec 31, 2018 | $10.06M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.46M | -12.4% |
| Q1 FY2026 | Mar 31, 2026 | $4.30M | +11.8% |
| Q4 FY2025 | Dec 31, 2025 | $8.37M | +29.7% |
| Q3 FY2025 | Sep 30, 2025 | $5.64M | +0.2% |
| Q2 FY2025 | Jun 30, 2025 | $5.10M | +40.9% |
| Q1 FY2025 | Mar 31, 2025 | $3.84M | +74.3% |
| Q4 FY2024 | Dec 31, 2024 | $6.45M | +22.0% |
| Q3 FY2024 | Sep 30, 2024 | $5.63M | +33.8% |
| Q2 FY2024 | Jun 30, 2024 | $3.62M | +24.6% |
| Q1 FY2024 | Mar 31, 2024 | $2.20M | +14.0% |
| Q4 FY2023 | Dec 31, 2023 | $5.29M | +49.7% |
| Q3 FY2023 | Sep 30, 2023 | $4.21M | +186.3% |
| Q2 FY2023 | Jun 30, 2023 | $2.90M | +189.8% |
| Q1 FY2023 | Mar 31, 2023 | $1.93M | -14.0% |
| Q4 FY2022 | Dec 31, 2022 | $3.53M | -24.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.47M | -49.7% |
| Q2 FY2022 | Jun 30, 2022 | $1.00M | -62.4% |
| Q1 FY2022 | Mar 31, 2022 | $2.25M | +68.8% |
| Q4 FY2021 | Dec 31, 2021 | $4.67M | -11.4% |
| Q3 FY2021 | Sep 30, 2021 | $2.92M | -27.7% |
| Q2 FY2021 | Jun 30, 2021 | $2.66M | -79.3% |
| Q1 FY2021 | Mar 31, 2021 | $1.33M | -71.1% |
| Q4 FY2020 | Dec 31, 2020 | $5.27M | +95.7% |
| Q3 FY2020 | Sep 30, 2020 | $4.04M | +84.8% |
| Q2 FY2020 | Jun 30, 2020 | $12.86M | +672.8% |
| Q1 FY2020 | Mar 31, 2020 | $4.62M | +99.3% |
| Q4 FY2019 | Dec 31, 2019 | $2.69M | -7.7% |
| Q3 FY2019 | Sep 30, 2019 | $2.19M | -12.9% |
| Q2 FY2019 | Jun 30, 2019 | $1.66M | -27.3% |
| Q1 FY2019 | Mar 31, 2019 | $2.32M | -1.1% |
| Q4 FY2018 | Dec 31, 2018 | $2.92M | – |
| Q3 FY2018 | Sep 30, 2018 | $2.51M | – |
| Q2 FY2018 | Jun 30, 2018 | $2.29M | – |
| Q1 FY2018 | Mar 31, 2018 | $2.34M | – |
See a number that looks wrong?